Abstract
The Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group was formed in 2008 as the first comprehensive cooperative trials group for genitourinary oncology in Australia and New Zealand, by the merger of the Australian Prostate and Urogenital cancer Group (APUG) and the Australian and New Zealand Germ Cell Trials Group (ANZGCTG), with funding from The Victorian Cancer Agency and subsequently from Cancer Australia. ANZUP's stated mission is to conduct clinical trial research to improve treatment of bladder, kidney, testicular and prostate cancers (http://www.anzup.org.au, accessed on 12 February 2015). To this end, it aims to bring together all the professional disciplines and groups involved in researching and treating urogenital cancers.
Original language | English |
---|---|
Pages (from-to) | 856-858 |
Number of pages | 3 |
Journal | BJU International |
Volume | 115 |
Issue number | 6 |
DOIs | |
Publication status | Published - 2015 |
Keywords
- cancer
- chemotherapy
- prostate